Morgan Stanley Lowers Meta Price Target to $775, Names New Top Pick
Morgan Stanley analyst Brian Nowak lowered the price target on Meta (NASDAQ: META) to $775.00 (from $825.00) while maintaining an Overweight rating.
“META sentiment has troughed due to GenAI ROIC and long-term positioning fears, and more recently macro ad market and regulatory question marks.
In all, META now trades at ~15X our ’27 $36 EPS, 1 standard deviation below the long-term average, which creates a strong buying opportunity, in our view.
Note too that our $36 of ’27 EPS 1) Considers some macro weakness (as we reduce ad estimates by 1% in ’26 to be more conservative) and 2) Does not factor in the potential $3-7bn of savings from the reported 20% potential workforce reductions (see here)…which all else equal could add $1+ to ’27 EPS (or provide cushion to our base case if ad markets weaken).
Our $775 PT has ~50% upside.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
